Mylan And Lupin Get EU Etanercept Nod
European Commission's Final Decision On Biosimilar Approval Due By May
Mylan, in partnership with Indian firm Lupin, will be looking to rival Biogen and Sandoz by introducing an etanercept biosimilar in European markets following a positive opinion by the EMA’s CHMP on Mylan's application.
